Format
Items per page

Send to:

Choose Destination

Search results

Items: 15

1.
2.

FAM83A protein, human [Supplementary Concept]

RefSeq NM_032899

Date introduced: July 21, 2008

3.

BJ-JN formulation [Supplementary Concept]

BJ-JN (also called Yuzhu Xiaogu), is a traditional Chinese medicine that prevents hepatic injury; consists of six crude drugs: Curcuma wenyujin Y.H. Chen & C. Ling (Zingiberaceae), Polyporus umbellatus (Pers.) Fries (Polyporaceae), Paeonia lactiflora Pall (Paeoniaceae), Areca catechu L (Arecaceae), Trionyx sinensis Wiegmann (Trionychidae) and Gallus gallus domesticus Brisson (Phasianidae)

Date introduced: January 24, 2007

4.

BJ 2000 [Supplementary Concept]

a combi-targeting compound; structure in first source

Date introduced: October 19, 2002

5.

FATE1 protein, human [Supplementary Concept]

RefSeq NM_033085

Date introduced: March 19, 2002

6.

Mamu-Mhc-BJ antigen [Supplementary Concept]

from Macaca mulatta; amino acid sequence given in first source; GenBank L41828

Date introduced: December 18, 1996

7.

PRO-10c protein, Bothrops jararaca [Supplementary Concept]

a proline-rich peptide with antihypertensive activity

Date introduced: February 8, 2012

8.

2-(4-acetyloxycyclohexylamino)-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-benzamide [Supplementary Concept]

has antiviral activity against HSV-1; structure in first source

Date introduced: July 3, 2011

9.

3-amino-2-imino-3,4-dihydro-2H-1,3-benzothiazin-4-one [Supplementary Concept]

structure in first source

Date introduced: June 17, 2004

10.

Bj-xtrIT toxin [Supplementary Concept]

amino acid sequence in first source

Date introduced: November 25, 1998

11.

BJ-1301 [Supplementary Concept]

aminopyridinol derivative of alpha-tocopherol; inhibits NADPH oxidase 2 (NOX2)

Date introduced: July 26, 2018

12.

BJ-2266 [Supplementary Concept]

downregulates the JAK/STAT signaling pathway; structure in first source

Date introduced: October 8, 2017

13.

BJ-3105 [Supplementary Concept]

has anti-inflammatory activity; inhibits IFN-gamma and IL-17 production; reduces Th1 and Th17 cell populations; structure in first source

Date introduced: August 20, 2017

14.
15.

BJ-1108 [Supplementary Concept]

an angiogenesis inhibitor with antineoplastic activity; structure in first source

Date introduced: July 10, 2016

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Loading ...
Support Center